Name
Study JR OÜ
Registry code
12631183
VAT number
EE101718042
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.03.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86221 - Provision of specialised medical treatment
122 840 €
11 488 €
9%
-
185 307 €
1
Submitted
No tax arrears
6%
6%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Julia Reinmets 26.05.1974 (50) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
ABConsult Plus OÜ 11591790 | - | - | - | Founder |
2019 25.06.2020 | 2020 21.06.2021 | 2021 14.06.2022 | 2022 22.06.2023 | 2023 23.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 183 751 € | 135 926 € | 35 164 € | 92 770 € | 122 840 € |
Net profit (loss) for the period | 48 012 € | 9 976 € | -33 176 € | 2 598 € | 11 488 € |
Profit Margin | 26% | 7% | -94% | 3% | 9% |
Current Assets | 106 216 € | 128 837 € | 111 088 € | 87 894 € | 105 976 € |
Fixed Assets | 135 602 € | 117 974 € | 100 346 € | 88 027 € | 81 044 € |
Total Assets | 241 818 € | 246 811 € | 211 434 € | 175 921 € | 187 020 € |
Current Liabilities | 7 397 € | 2 414 € | 213 € | 2 102 € | 1 713 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 234 421 € | 244 397 € | 211 221 € | 173 819 € | 185 307 € |
Employees | 6 | 5 | 1 | 1 | 1 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 31 147.54 € | 7 419.29 € | 691.3 € | 6 |
2023 Q4 | - | 156.84 € | 170.04 € | 6 |
2023 Q3 | - | 379.2 € | 411.12 € | 6 |
2023 Q2 | - | 1 714.68 € | 1 838.9 € | 6 |
2023 Q1 | - | 1 699.37 € | 1 790.3 € | 29 |
2022 Q4 | 2 900 € | 812 € | 866.6 € | 29 |
2022 Q3 | - | 11 139.68 € | 1 214.45 € | 29 |
2022 Q2 | 3 307.2 € | 156.84 € | 170.04 € | 29 |
2022 Q1 | 457.01 € | 187.34 € | 170.04 € | 29 |
2021 Q4 | 2 931 € | 156.84 € | 170.04 € | 29 |
2021 Q3 | 7 837 € | 156.84 € | 170.04 € | 29 |
2021 Q2 | - | 203.89 € | 221.05 € | 29 |
2021 Q1 | 16 804.09 € | 2 172.08 € | 2 315.5 € | 29 |
2020 Q4 | 31 262.16 € | 2 698.85 € | 2 919.88 € | 29 |
2020 Q3 | 15 817.83 € | 158.04 € | 165.24 € | 29 |
2020 Q2 | 42 439.93 € | 4 227.25 € | 4 575.58 € | 29 |
2020 Q1 | 77 484.88 € | 4 654.2 € | 4 459.16 € | 29 |